Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Too much topical minoxidil can cause excessive hair growth, but stopping treatment reverses it.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

The healthcare for transgender veterans could be better with a more unified team approach.

A group has developed therapies that show promise for treating cancer and various other conditions.

Early NAS level changes affect alcohol consumption vulnerability.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.